Search Results
Overview
| Uniprot ID | P14550 |
|---|---|
| Protein Name | Aldo-keto reductase family 1 member A1 |
| Gene Name | AKR1A1 |
| Organism | Homo sapiens |
Kla Sites from experimental identification
| Position | Flanking peptide |
|---|---|
| 127 | RGDNPFPKNADGTIC |
| 13 | VLLHTGQKMPLIGLG |
| 141 | CYDSTHYKETWKALE |
| 294 | KQLNALNKNWRYIVP |
| 30 | KSEPGQVKAAVKYAL |
| 308 | PMLTVDGKRVPRDAG |
| 68 | KEDVGPGKAVPREEL |
| 80 | EELFVTSKLWNTKHH |
| 85 | TSKLWNTKHHPEDVE |
Function
Catalyzes the NADPH-dependent reduction of a wide variety of carbonyl-containing compounds to their corresponding alcohols (PubMed:10510318, PubMed:30538128). Displays enzymatic activity towards endogenous metabolites such as aromatic and aliphatic aldehydes, ketones, monosaccharides and bile acids, with a preference for negatively charged substrates, such as glucuronate and succinic semialdehyde (PubMed:10510318, PubMed:30538128). Functions as a detoxifiying enzyme by reducing a range of toxic aldehydes (By similarity). Reduces methylglyoxal and 3-deoxyglucosone, which are present at elevated levels under hyperglycemic conditions and are cytotoxic (By similarity). Involved also in the detoxification of lipid-derived aldehydes like acrolein (By similarity). Plays a role in the activation of procarcinogens, such as polycyclic aromatic hydrocarbon trans-dihydrodiols, and in the metabolism of various xenobiotics and drugs, including the anthracyclines doxorubicin (DOX) and daunorubicin (DAUN) (PubMed:11306097, PubMed:18276838). Also acts as an inhibitor of protein S-nitrosylation by mediating degradation of S-nitroso-coenzyme A (S-nitroso-CoA), a cofactor required to S-nitrosylate proteins (PubMed:30538128). S-nitroso-CoA reductase activity is involved in reprogramming intermediary metabolism in renal proximal tubules, notably by inhibiting protein S-nitrosylation of isoform 2 of PKM (PKM2) (By similarity). Also acts as a S-nitroso-glutathione reductase by catalyzing the NADPH-dependent reduction of S-nitrosoglutathione (PubMed:31649033). Displays no reductase activity towards retinoids (By similarity)
Protein Sequence
Gene Ontology
| Classification | GO ID | Description |
|---|---|---|
| Cellular Component | GO:0016324 | apical plasma membrane |
| Biological Process | GO:0043066 | negative regulation of apoptotic process |
| Cellular Component | GO:0005829 | cytosol |
| Cellular Component | GO:0070062 | extracellular exosome |
| Cellular Component | GO:0005615 | extracellular space |
| Cellular Component | GO:0045202 | synapse |
| Molecular Function | GO:0008106 | alcohol dehydrogenase (NADP+) activity |
| Molecular Function | GO:0004032 | aldose reductase (NADPH) activity |
| Molecular Function | GO:0047655 | allyl-alcohol dehydrogenase activity |
| Molecular Function | GO:0047941 | glucuronolactone reductase activity |
| Molecular Function | GO:0047956 | glycerol dehydrogenase (NADP+) activity |
| Molecular Function | GO:0047939 | L-glucuronate reductase activity |
| Molecular Function | GO:1990002 | methylglyoxal reductase (NADPH) (acetol producing) activity |
| Molecular Function | GO:0080007 | S-nitrosoglutathione reductase (NADH) activity |
| Molecular Function | GO:0160163 | S-nitrosoglutathione reductase (NADPH) activity |
| Biological Process | GO:0046185 | aldehyde catabolic process |
| Biological Process | GO:0110095 | cellular detoxification of aldehyde |
| Biological Process | GO:0019640 | D-glucuronate catabolic process to D-xylulose 5-phosphate |
| Biological Process | GO:0044597 | daunorubicin metabolic process |
| Biological Process | GO:0044598 | doxorubicin metabolic process |
| Biological Process | GO:1901687 | glutathione derivative biosynthetic process |
| Biological Process | GO:0006629 | lipid metabolic process |
Reference
[1] Yang Z, Yan C, Ma J, Peng P, Ren X et al.. Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma.. Nat Metab 5(1):61-79. 2023 Jan. PMID: 36593272.
[2] Hong H, Chen X, Wang H, Gu X, Yuan Y et al.. Global profiling of protein lysine lactylation and potential target modified protein analysis in hepatocellular carcinoma.. Proteomics 23(9):e2200432. 2023 May. PMID: 36625413.